Announcements Trials

Browse Landscape

Phase

Phase 1 9 Phase 2/3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Pemetrexed 23 Carboplatin 21 Cisplatin 20 pembrolizumab 15 Docetaxel 14 Paclitaxel 10 Gemcitabine 8 Drug Therapy 7 Bevacizumab 7 Gefitinib 5 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Erlotinib Hydrochloride 4 130-nm albumin-bound paclitaxel 4 cemiplimab 3 atezolizumab 3 anlotinib 3 Dexamethasone 3 dexamethasone acetate 2 dexamethasone 21-phosphate 2 cobimetinib 2 auricularum 2 aumolertinib 2 apatinib 2 Vemurafenib 2 Topotecan 2 Temozolomide 2 Surgical Procedures, Operative 2 Standard of Care 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × budigalimab × Thoracic × Clear all

NCT06236438 2026-02-23

LIVIGNO-4

AbbVie

Phase 2/3 Recruiting

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡